ST6GAL1 and prostate carcinoma: Previous studies have indeed reported that cancer cells, including prostate cancer cells, can release functional ST6GAL122,82 and our clinical data further demonstrates increased blood borne ST6GAL1 in men with aggressive prostate cancer.